drugset / Trial / NCT00331825

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

NCT00331825

RandomizedParallel-groupSingle-blindTreatment

Summary

We initiate a study with research grant from department of health and Taoyuan mental hospital and choose risperidone and olanzapine as study medications. We compare the incidence of using anticholinergic drugs in schizophrenic patients of Han ethnics with neuroleptic-induced acute dystonia or parkinsonism to test the hypothesis that these two medications have different EPS incidence in EPS intolerant population.

Timeline

Start
2000-07
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Risperidone Other / unclassified